|
1
|
Li FP and Fraumeni JF Jr: Soft-tissue
sarcomas, breast cancer, and other neoplasms. A familial syndrome?
Ann Intern Med. 71:747–752. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hisada M, Garber JE, Fung CY, Fraumeni JF
Jr and Li FP: Multiple primary cancers in families with Li-Fraumeni
syndrome. J Natl Cancer Inst. 90:606–611. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olivier M, Hollstein M and Hainaut P: TP53
mutations in human cancers: Origins, consequences, and clinical
use. Cold Spring Harb Perspect Biol. 2:a0010082010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bell DW, Varley JM, Szydlo TE, Kang DH,
Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ,
Fraumeni JF, et al: Heterozygous germ line hCHK2 mutations in
Li-Fraumeni syndrome. Science. 286:2528–2531. 1999. View Article : Google Scholar
|
|
5
|
Bachinski LL, Olufemi S-E, Zhou X, Wu CC,
Yip L, Shete S, Lozano G, Amos CI, Strong LC and Krahe R: Genetic
mapping of a third Li-Fraumeni syndrome predisposition locus to
human chromosome 1q23. Cancer Res. 65:427–431. 2005.PubMed/NCBI
|
|
6
|
Chen K, Wallis JW, McLellan MD, Larson DE,
Kalicki JM, Pohl CS, McGrath SD, Wendl MC, Zhang Q, Locke DP, et
al: BreakDancer: An algorithm for high-resolution mapping of
genomic structural variation. Nat Methods. 6:677–681. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boeva V, Popova T, Bleakley K, Chiche P,
Cappo J, Schleiermacher G, Janoueix-Lerosey I, Delattre O and
Barillot E: Control-FREEC: A tool for assessing copy number and
allelic content using next-generation sequencing data.
Bioinformatics. 28:423–425. 2012. View Article : Google Scholar :
|
|
8
|
Cibulskis K, Lawrence MS, Carter SL,
Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES
and Getz G: Sensitive detection of somatic point mutations in
impure and heterogeneous cancer samples. Nat Biotechnol.
31:213–219. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gilissen C, Hoischen A, Brunner HG and
Veltman JA: Disease gene identification strategies for exome
sequencing. Eur J Hum Genet. 20:490–497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garber JE and Offit K: Hereditary cancer
predisposition syndromes. J Clin Oncol. 23:276–292. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wood RD, Mitchell M, Sgouros J and Lindahl
T: Human DNA repair genes. Science. 291:1284–1289. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramensky V, Bork P and Sunyaev S: Human
non-synonymous SNPs: Server and survey. Nucleic Acids Res.
30:3894–3900. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen R, Davydov EV, Sirota M and Butte AJ:
Non-synonymous and synonymous coding SNPs show similar likelihood
and effect size of human disease association. PLoS One.
5:e135742010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashley EA, Butte AJ, Wheeler MT, Chen R,
Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, et
al: Clinical assessment incorporating a personal genome. Lancet.
375:1525–1535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
1000 Genomes Project Consortium; Abecasis
GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang
HM, Marth GT and McVean GA: An integrated map of genetic variation
from 1,092 human genomes. Nature. 491:56–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mwenifumbo JC and Marra MA: Cancer
genome-sequencing study design. Nat Rev Genet. 14:321–332. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malkin D, Jolly KW, Barbier N, Look AT,
Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J,
et al: Germline mutations of the p53 tumor-suppressor gene in
children and young adults with second malignant neoplasms. N Engl J
Med. 326:1309–1315. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sugano K, Taniguchi T, Saeki M, Tsunematsu
Y, Tomaru U and Shimoda T: Germline p53 mutation in a case of
Li-Fraumeni syndrome presenting gastric cancer. Jpn J Clin Oncol.
29:513–516. 1999. View Article : Google Scholar
|
|
19
|
Healey CS, Dunning AM, Teare MD, Chase D,
Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman
DG, et al: A common variant in BRCA2 is associated with both breast
cancer risk and prenatal viability. Nat Genet. 26:362–364. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masciari S, Larsson N, Senz J, Boyd N,
Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P,
et al: Germline E-cadherin mutations in familial lobular breast
cancer. J Med Genet. 44:726–731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaurah P, MacMillan A, Boyd N, Senz J, De
Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, et al:
Founder and recurrent CDH1 mutations in families with hereditary
diffuse gastric cancer. JAMA. 297:2360–2372. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mohaghegh P and Hickson ID: DNA helicase
deficiencies associated with cancer predisposition and premature
ageing disorders. Hum Mol Genet. 10:741–746. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kitao S, Shimamoto A, Goto M, Miller RW,
Smithson WA, Lindor NM and Furuichi Y: Mutations in RECQL4 cause a
subset of cases of Rothmund-Thomson syndrome. Nat Genet. 22:82–84.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ellis NA, Groden J, Ye TZ, Straughen J,
Lennon DJ, Ciocci S, Proytcheva M and German J: The Bloom's
syndrome gene product is homologous to RecQ helicases. Cell.
83:655–666. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thompson ER, Doyle MA, Ryland GL, Rowley
SM, Choong DY, Tothill RW, Thorne H, Barnes DR, Li J, Ellul J, et
al: kConFab: Exome sequencing identifies rare deleterious mutations
in DNA repair genes FANCC and BLM as potential breast cancer
susceptibility alleles. PLoS Genet. 8:e10028942012. View Article : Google Scholar
|
|
26
|
Kunkel TA and Erie DA: DNA mismatch
repair. Annu Rev Biochem. 74:681–710. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakagawa H, Lockman JC, Frankel WL, Hampel
H, Steenblock K, Burgart LJ, Thibodeau SN and de la Chapelle A:
Mismatch repair gene PMS2: Disease-causing germline mutations are
frequent in patients whose tumors stain negative for PMS2 protein,
but paralogous genes obscure mutation detection and interpretation.
Cancer Res. 64:4721–4727. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hitchins MP, Wong JJL, Suthers G, Suter
CM, Martin DIK, Hawkins NJ and Ward RL: Inheritance of a
cancer-associated MLH1 germ-line epimutation. N Engl J Med.
356:697–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Forbes SA, Bindal N, Bamford S, Cole C,
Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al:
COSMIC: Mining complete cancer genomes in the Catalogue of Somatic
Mutations in Cancer. Nucleic Acids Res. 39(Database): D945–D950.
2011. View Article : Google Scholar :
|
|
30
|
Chen C, Liu Y, Rappaport AR, Kitzing T,
Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, et
al: MLL3 is a haploinsufficient 7q tumor suppressor in acute
myeloid leukemia. Cancer Cell. 25:652–665. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li WD, Li QR, Xu SN, Wei FJ, Ye ZJ, Cheng
JK and Chen JP: Exome sequencing identifies an MLL3 gene germ line
mutation in a pedigree of colorectal cancer and acute myeloid
leukemia. Blood. 121:1478–1479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Villani A, Tabori U, Schiffman J, Shlien
A, Beyene J, Druker H, Novokmet A, Finlay J and Malkin D:
Biochemical and imaging surveillance in germline TP53 mutation
carriers with Li-Fraumeni syndrome: A prospective observational
study. Lancet Oncol. 12:559–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Haferlach C, Dicker F, Herholz H,
Schnittger S, Kern W and Haferlach T: Mutations of the TP53 gene in
acute myeloid leukemia are strongly associated with a complex
aberrant karyotype. Leukemia. 22:1539–1541. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Grochola LF, Zeron-Medina J, Mériaux S and
Bond GL: Single-nucleotide polymorphisms in the p53 signaling
pathway. Cold Spring Harb Perspect Biol. 2:a0010322010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fitzgerald RC, Hardwick R, Huntsman D,
Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K,
Van Krieken JH, et al International Gastric Cancer Linkage
Consortium: Hereditary diffuse gastric cancer: Updated consensus
guidelines for clinical management and directions for future
research. J Med Genet. 47:436–444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Evans DGR and Ingham SL: Reduced life
expectancy seen in hereditary diseases which predispose to
early-onset tumors. Appl Clin Genet. 6:53–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Limacher JM, Frebourg T, Natarajan-Ame S
and Bergerat JP: Two metachronous tumors in the radiotherapy fields
of a patient with Li-Fraumeni syndrome. Int J Cancer. 96:238–242.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Heymann S, Delaloge S, Rahal A, Caron O,
Frebourg T, Barreau L, Pachet C, Mathieu MC, Marsiglia H and
Bourgier C: Radio-induced malignancies after breast cancer
postoperative radiotherapy in patients with Li-Fraumeni syndrome.
Radiat Oncol. 5:1042010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Godley LA and Larson RA: Therapy-related
myeloid leukemia. Semin Oncol. 35:418–429. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Smith MA, Rubinstein L, Anderson JR,
Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land
VJ, et al: Secondary leukemia or myelodysplastic syndrome after
treatment with epipodophyllotoxins. J Clin Oncol. 17:569–577.
1999.PubMed/NCBI
|
|
42
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rausch T, Jones DTW, Zapatka M, Stütz AM,
Zichner T, Weischenfeldt J, Jäger N, Remke M, Shih D, Northcott PA,
et al: Genome sequencing of pediatric medulloblastoma links
catastrophic DNA rearrangements with TP53 mutations. Cell.
148:59–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
